BioCentury
ARTICLE | Clinical News

Anavex preclinical data

September 27, 2010 7:00 AM UTC

In a non-transgenic mouse model of AD, 300 µg/kg ANAVEX 2-73 reversed learning deficits associated with injection of the beta amyloid 25-35 peptide. Furthermore, simultaneous injection of ANAVEX 2-73...